These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28286060)

  • 1. A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.
    Yamayoshi S; Uraki R; Ito M; Kiso M; Nakatsu S; Yasuhara A; Oishi K; Sasaki T; Ikuta K; Kawaoka Y
    EBioMedicine; 2017 Mar; 17():182-191. PubMed ID: 28286060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.
    Huang J; Huang N; Fan M; Zhao L; Luo Y; Ding P; Tian M; Liu Q; Guo Y; Zhao J; Zheng Y; Zhang H; Ping J
    Virol J; 2020 Dec; 17(1):191. PubMed ID: 33287849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.
    Yamayoshi S; Ito M; Uraki R; Sasaki T; Ikuta K; Kawaoka Y
    J Infect; 2018 Feb; 76(2):177-185. PubMed ID: 29248585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.
    Yamayoshi S; Yasuhara A; Ito M; Uraki R; Kawaoka Y
    J Clin Virol; 2018 Nov; 108():105-111. PubMed ID: 30292135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
    Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
    J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
    Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
    Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
    Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of hemagglutinin targeted influenza virus neutralization.
    Brandenburg B; Koudstaal W; Goudsmit J; Klaren V; Tang C; Bujny MV; Korse HJ; Kwaks T; Otterstrom JJ; Juraszek J; van Oijen AM; Vogels R; Friesen RH
    PLoS One; 2013; 8(12):e80034. PubMed ID: 24348996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies.
    Wyrzucki A; Bianchi M; Kohler I; Steck M; Hangartner L
    J Virol; 2015 Mar; 89(6):3136-44. PubMed ID: 25552718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics.
    Winarski KL; Tang J; Klenow L; Lee J; Coyle EM; Manischewitz J; Turner HL; Takeda K; Ward AB; Golding H; Khurana S
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15194-15199. PubMed ID: 31296560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody.
    Sano K; Saito S; Suzuki T; Kotani O; Ainai A; van Riet E; Tabata K; Saito K; Takahashi Y; Yokoyama M; Sato H; Maruno T; Usami K; Uchiyama S; Ogawa-Goto K; Hasegawa H
    PLoS One; 2021; 16(1):e0245244. PubMed ID: 33412571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of epitopes from influenza A virus hemagglutinin that induce broadly cross-reactive antibodies.
    Li Y; Hu H; Qi Z; Sun J; Li Y; Feng Q; Guo C; Wang H; Zhao P; Liu Y; Zhao X; Wang G; Zhang H; Liu L; Hu J
    Int J Mol Med; 2018 Mar; 41(3):1673-1682. PubMed ID: 29286160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin.
    Stropkovská A; Mucha V; Fislová T; Gocník M; Kostolanský F; Varecková E
    Acta Virol; 2009; 53(1):15-20. PubMed ID: 19301946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
    Manceur AP; Zou W; Marcil A; Paquet E; Gadoury C; Jaentschke B; Li X; Petiot E; Durocher Y; Baardsnes J; Rosa-Calatrava M; Ansorge S; Kamen AA
    PLoS One; 2017; 12(6):e0180314. PubMed ID: 28662134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses.
    Kotani O; Suzuki Y; Saito S; Ainai A; Ueno A; Hemmi T; Sano K; Tabata K; Yokoyama M; Suzuki T; Hasegawa H; Sato H
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.
    Bächi T; Gerhard W; Yewdell JW
    J Virol; 1985 Aug; 55(2):307-13. PubMed ID: 2410628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus.
    Wu Y; Cho M; Shore D; Song M; Choi J; Jiang T; Deng YQ; Bourgeois M; Almli L; Yang H; Chen LM; Shi Y; Qi J; Li A; Yi KS; Chang M; Bae JS; Lee H; Shin J; Stevens J; Hong S; Qin CF; Gao GF; Chang SJ; Donis RO
    Nat Commun; 2015 Jul; 6():7708. PubMed ID: 26196962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of a recombinant broadly-reactive monoclonal antibody against group 1 and 2 influenza viruses.
    Hu Z; Huang Y; Zhao J; Hu J; Hu S; Liu X
    Protein Expr Purif; 2022 Apr; 192():106046. PubMed ID: 35007721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
    Baranovich T; Jones JC; Russier M; Vogel P; Szretter KJ; Sloan SE; Seiler P; Trevejo JM; Webby RJ; Govorkova EA
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2118-31. PubMed ID: 26787699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.